Results 101 to 110 of about 17,241 (223)

Current Evidence on the Use of Antifilarial Agents in the Management of Bancroftian Filariasis [PDF]

open access: yes, 2020
Many trials have explored the efficacy of individual drugs and drug combinations to treat bancroftian filariasis. This narrative review summarizes the current evidence for drug management of bancroftian filariasis.
Senaka Rajapakse   +2 more
core  

The Abundant Larval Transcript-1 and -2 Genes ofBrugia malayi Encode Stage-Specific Candidate Vaccine Antigens for Filariasis

open access: yes, 2000
Lymphatic filariasis is a major tropical disease caused by the mosquito-borne nematodes Brugia and Wuchereria. About 120 million people are infected and at risk of lymphatic pathology such as acute lymphangitis and elephantiasis.
Allen, Judith   +4 more
core  

Bancroftian filariasis among the Mbembe people of Cross River state, Nigeria [PDF]

open access: yesJournal of Vector Borne Diseases, 2010
Background & objective: Bancroftian filariasis is a major public health and socioeconomic problemsin the humid tropical and subtropical regions of the world.
O.E. Okon, C.I. Iboh, K.N. Opara
doaj  

On the Familial Infection of Bancroftian Filariasis due to the House Mosquitoes [PDF]

open access: yes, 1965
In Japan and Ryukyus where bancroftian filariasis is being transmitted respectively by Culex pipiens pallens and C. p. fatigans which are very domestic in breeding, resting, and feeding habits, the transmission of the disease is characterized by a from ...
Omori, Nanzaburo
core  

Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: a threat to filariasis elimination status?

open access: yesParasites & Vectors, 2018
Background Post-mass drug administration (MDA) surveillance during the lymphatic filariasis (LF) elimination program in Sri Lanka, revealed the re-emergence of brugian filariasis after four decades.
Chandana H. Mallawarachchi   +4 more
doaj   +1 more source

Bancroftian filariasis in the Sudan.

open access: yesBulletin of the World Health Organization, 1975
The authors present and discuss the results of a survey carried out in the Farbronga and Habeila areas and in the Nuba mountains of the Sudan to ascertain the incidence of filariasis due to Wuchereria bancrofti.
M H, Satti, O M, Abdel Nur
openaire   +1 more source

Use of mebendazole in combination with DEC in bancroftian filariasis [PDF]

open access: yes, 1988
A pilot study was conducted in an endemic village for bancroftian filariasis to find out the compliance and antifilarial action of large doses of mebendazole (30 mg/kg/day).
Nagabhushana Rao, R S   +4 more
core  

A POLYMERASE CHAIN REACTION ASSAY FOR THE SURVEY OF BANCROFTIAN FILARIASIS [PDF]

open access: yes, 2020
. A polymerase chain reaction (PCR) assay based on a highly repeated DNA sequence found in Wuchereria bancrofti (SspI repeat) has been modified for the survey of bancroftian filariasis in expatriate workers (Myamese, Karen and Mon) from Myanmar where ...

core  

Treatment of co-infection with bancroftian filariasis and onchocerciasis: A safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis: A safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis

open access: yes, 2003
Background: In order to use a combination of ivermectin and albendazole for the elimination of lymphatic filariasis, it is important to assess the potential risk of increased adverse events in individuals infected with both lymphatic filariasis and ...
Rachel W Makunde   +15 more
core   +1 more source

“String sign”- acute lymphangitis in the forearm following triple drug therapy for bancroftian filarial infection

open access: yesJournal of Vector Borne Diseases
Localized adverse events following mass drug administration for lymphatic filariasis elimination are often selflimiting. However, they are of significant concern to the participants and may affect community drug compliance if not managed appropriately ...
Vijesh Sreedhar Kuttiatt   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy